Novel 2-phenyl-4,5,6,7-tetrahydro[ b ]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies-Reference-Cited by-同舟云学术

Novel 2-phenyl-4,5,6,7-tetrahydro[ b ]benzothiophene analogues as selective COX-2 inhibitors: Design, synthesis, anti-inflammatory evaluation, and molecular docking studies

Published:2017-04 Issue:8 Volume:27 Page:1721-1726
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Khatri Chetan K.,Indalkar Krishna S.,Patil Chandragouda R.,Goyal Sameer N.,Chaturbhuj Ganesh U.

Funder

University Grants Commission

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference25 articles.

1. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence

2. Clinical Pharmacokinetics of Diclofenac

3. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-Enaminonitrile in the synthesis of tetrahydrobenzo[b]thiophene candidates with DFT simulation, in vitro antiproliferative assessment, molecular docking, and modeling pharmacokinetics;RSC Advances;2024

2. Prevention of Testicular Damage by Indole Derivative MMINA via Upregulated StAR and CatSper Channels with Coincident Suppression of Oxidative Stress and Inflammation: In Silico and In Vivo Validation;Antioxidants;2022-10-19

3. Antiproliferative and Antiprostate Cancer Activities of Heterocyclic Compounds Derived from Cyclohexane-1,4-dione;Acta Chimica Slovenica;2022-09-26

4. Sulindac acetohydrazide derivative attenuates against cisplatin induced organ damage by modulation of antioxidant and inflammatory signaling pathways;Scientific Reports;2022-07-11

5. Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years;Acta Pharmaceutica Sinica B;2022-06